Literature DB >> 18520039

Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells.

Yuki Masuda1, Yukihito Murata, Masahiko Hayashi, Hiroaki Nanba.   

Abstract

The anti-metastatic activity of MD-Fraction extracted from the maitake mushroom (Grifola frondosa) was examined in an experimental murine model of lung metastasis. Intraperitoneal administration of MD-Fraction 2 d before tumor implantation significantly inhibited lung metastasis of colon-26 carcinoma and B16/BL6 melanoma cells. In this model, MD-Fraction enhanced IL-12 production from antigen presenting cells (APCs). MD-Fraction treatment activated NK cells and increased cytotoxicity against YAC-1 and colon-26 carcinoma cells. Furthermore, the depletion of NK cells with anti-asialo GM1 abolished the inhibitory effect of MD-Fraction on lung metastasis of colon-26 cells. Ex vivo, B16/BL6 cell adhesion to LPS-activated murine lung vascular endothelial cells was inhibited by MD-Fraction and anti-intercellular adhesion molecule (ICAM)-1 antibody. These results suggest that MD-Fraction inhibits tumor metastasis by activating NK cells and APCs, and by suppressing of ICAM-1 leading to the inhibition of tumor cell adhesion to vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520039     DOI: 10.1248/bpb.31.1104

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis.

Authors:  Yulin Ren; Chunhua Yuan; Youcai Deng; Ragu Kanagasabai; Tran Ngoc Ninh; Vuong Tan Tu; Hee-Byung Chai; Djaja D Soejarto; James R Fuchs; Jack C Yalowich; Jianhua Yu; A Douglas Kinghorn
Journal:  Phytochemistry       Date:  2015-01-14       Impact factor: 4.072

2.  Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases.

Authors:  Zongmin Zhao; Anvay Ukidve; Vinu Krishnan; Alexandra Fehnel; Daniel C Pan; Yongsheng Gao; Jayoung Kim; Michael A Evans; Abhirup Mandal; Junling Guo; Vladimir R Muzykantov; Samir Mitragotri
Journal:  Nat Biomed Eng       Date:  2020-11-16       Impact factor: 25.671

Review 3.  Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.

Authors:  Alena G Guggenheim; Kirsten M Wright; Heather L Zwickey
Journal:  Integr Med (Encinitas)       Date:  2014-02

4.  Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Authors:  Kathleen M Wesa; Susanna Cunningham-Rundles; Virginia M Klimek; Emily Vertosick; Marci I Coleton; K Simon Yeung; Hong Lin; Stephen Nimer; Barrie R Cassileth
Journal:  Cancer Immunol Immunother       Date:  2014-10-29       Impact factor: 6.968

5.  Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.

Authors:  Agustina Roldan-Deamicis; Eliana Alonso; Belén Brie; Diego Aguilera Braico; Gabriela Andrea Balogh
Journal:  Cancer Med       Date:  2016-07-11       Impact factor: 4.452

Review 6.  Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era.

Authors:  Iwona Mirończuk-Chodakowska; Karolina Kujawowicz; Anna Maria Witkowska
Journal:  Nutrients       Date:  2021-11-06       Impact factor: 5.717

Review 7.  Immunomodulatory functional foods and their molecular mechanisms.

Authors:  Jae Hwan Kim; Da Hyun Kim; Seongin Jo; Min Je Cho; Ye Ryeong Cho; Yong Joon Lee; Sanguine Byun
Journal:  Exp Mol Med       Date:  2022-01-25       Impact factor: 12.153

Review 8.  Mushrooms as Potential Sources of Active Metabolites and Medicines.

Authors:  Anne Bhambri; Malay Srivastava; Vivek G Mahale; Sushma Mahale; Santosh Kumar Karn
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 6.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.